Dieses Ergebnis aus Springer Nature Journals kann Gästen nicht angezeigt werden. Login für vollen Zugriff.

Isatuximab, carfilzomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma: a randomized phase 3 trial

Title:	Isatuximab, carfilzomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma: a randomized phase 3 trial
Authors:	Gay, Francesca^{Aff1, IDs41591026042820_cor1}; Roeloffzen, Wilfried^Aff2; Dimopoulos, Meletios A.^{Aff3, Aff4}; Rosiñol, Laura^Aff5; van der Klift, Marjolein^Aff6; Mina, Roberto^Aff1; Oriol, Albert^Aff7; Katodritou, Eirini^Aff8; Wu, Ka Lung^Aff9; Rodríguez Otero, Paula^Aff10; Hájek, Roman^{Aff11, Aff12}; Antonioli, Elisabetta^Aff13; van Duin, Mark^Aff14; D’Agostino, Mattia^Aff1; Martínez-López, Joaquín^Aff15; van Leeuwen-Segarceanu, Elena M.^Aff16; Zamagni, Elena^{Aff17, Aff18}; van de Donk, Niels W. C. J.^Aff19; Weisel, Katja C.^Aff20; Pour, Luděk^Aff21; Radocha, Jakub^Aff22; Belotti, Angelo^Aff23; Schjesvold, Fredrik^{Aff24, Aff25}; Bladé, Joan^Aff5; Einsele, Hermann^Aff26; Sonneveld, Pieter^{Aff14, Aff27}; Boccadoro, Mario^Aff28; Broijl, Annemiek^Aff14
Source:	Nature Medicine. 32(5):1773-1782
Database:	Springer Nature Journals